FHIR IG analytics
| Package | hl7.fhir.uv.shc-vaccination |
| Resource Type | ValueSet |
| Id | ValueSet-immunization-all-cvx.json |
| FHIR Version | R4 |
| Source | https://build.fhir.org/ig/HL7/fhir-shc-vaccination-ig/ValueSet-immunization-all-cvx.html |
| URL | http://hl7.org/fhir/uv/shc-vaccination/ValueSet/immunization-all-cvx |
| Version | 1.0.0 |
| Status | active |
| Date | 2025-09-03T20:15:06+00:00 |
| Name | ImmunizationAllCvxValueSet |
| Title | Immunization / All / CVX |
| Realm | uv |
| Authority | hl7 |
| Description | Contains all CVX codes from <https://www2.cdc.gov/vaccines/iis/iisstandards/vaccines.asp?rpt=cvx> as of 2025-09-03. This list of codes will not update automatically, so please refer to this URL for
the most up-to-date codes.the most up-to-date codes. |
Resources that use this resource
Resources that this resource uses
| CodeSystem |
| cvx | CVX codes used in this IG |
Narrative
Note: links and images are rebased to the (stated) source
- Include these codes as defined in
http://hl7.org/fhir/sid/cvx| Code | Display |
| 54 | adenovirus, type 4 |
| 55 | adenovirus, type 7 |
| 82 | adenovirus, unspecified formulation |
| 24 | Anthrax, pre-exposure prophylaxis, post-exposure prophylaxis |
| 19 | BCG |
| 27 | botulinum antitoxin |
| 26 | cholera, unspecified formulation |
| 29 | CMVIG |
| 56 | dengue fever tetravalent |
| 12 | diphtheria antitoxin |
| 28 | DT (pediatric) |
| 20 | DTaP |
| 106 | DTaP, 5 pertussis antigens |
| 107 | DTaP, unspecified formulation |
| 110 | DTaP-Hep B-IPV |
| 50 | DTaP-Hib |
| 120 | DTaP-Hib-IPV |
| 130 | DTaP-IPV |
| 22 | DTP-Hib |
| 102 | DTP-Hib-Hep B |
| 57 | hantavirus |
| 52 | Hep A, adult |
| 83 | Hep A, ped/adol, 2 dose |
| 84 | Hep A, ped/adol, 3 dose |
| 31 | Hep A, pediatric, unspecified formulation |
| 85 | Hep A, unspecified formulation |
| 104 | Hep A-Hep B |
| 30 | HBIG |
| 42 | Hep B, adolescent/high risk infant |
| 43 | Hep B, adult |
| 44 | Hep B, high-dosage, dialysis or IC |
| 45 | Hep B, unspecified formulation |
| 58 | Hep C |
| 59 | Hep E |
| 60 | herpes simplex 2 |
| 46 | Hib (PRP-D) |
| 47 | Hib (HbOC) |
| 48 | Hib (PRP-T) |
| 49 | Hib (PRP-OMP) |
| 17 | Hib, unspecified formulation |
| 51 | Hib-Hep B |
| 61 | HIV |
| 118 | HPV, bivalent |
| 62 | HPV, quadrivalent |
| 86 | IG |
| 87 | IGIV |
| 14 | IG, unspecified formulation |
| 111 | Influenza, live, trivalent, intranasal, PF |
| 15 | influenza, split (incl. purified surface antigen) |
| 16 | influenza, whole |
| 88 | influenza, unspecified formulation |
| 123 | influenza, H5N1-1203 |
| 10 | IPV |
| 89 | polio, unspecified formulation |
| 39 | Japanese encephalitis SC |
| 63 | Junin virus |
| 64 | leishmaniasis |
| 65 | leprosy |
| 66 | Lyme disease |
| 94 | MMRV |
| 67 | malaria |
| 68 | melanoma |
| 32 | meningococcal MPSV4 |
| 103 | meningococcal C conjugate |
| 114 | meningococcal MCV4P |
| 108 | meningococcal ACWY, unspecified formulation |
| 69 | parainfluenza-3 |
| 11 | pertussis |
| 23 | plague |
| 33 | pneumococcal polysaccharide PPV23 |
| 100 | pneumococcal conjugate PCV 7 |
| 109 | pneumococcal, unspecified formulation |
| 70 | Q fever |
| 18 | rabies, intramuscular injection |
| 40 | rabies, intradermal injection |
| 90 | rabies, unspecified formulation |
| 72 | rheumatic fever |
| 73 | Rift Valley fever |
| 34 | RIG |
| 119 | rotavirus, monovalent |
| 122 | rotavirus, unspecified formulation |
| 116 | rotavirus, pentavalent |
| 74 | rotavirus, tetravalent |
| 71 | RSV-IGIV |
| 93 | RSV-MAb |
| 38 | rubella/mumps |
| 76 | Staphylococcus bacterio lysate |
| 113 | Td (adult), 5 Lf tetanus toxoid, preservative free, adsorbed |
| 115 | Tdap |
| 35 | tetanus toxoid, adsorbed |
| 112 | tetanus toxoid, unspecified formulation |
| 77 | Tick-borne encephalitis vaccine (non-US) |
| 13 | TIG |
| 95 | TST-OT tine test |
| 96 | TST-PPD intradermal |
| 97 | TST-PPD tine test |
| 98 | TST, unspecified formulation |
| 78 | tularemia vaccine |
| 91 | typhoid, unspecified formulation |
| 25 | typhoid, oral |
| 41 | typhoid, parenteral |
| 53 | typhoid, parenteral, AKD (U.S. military) |
| 101 | typhoid, ViCPs |
| 75 | Vaccinia (smallpox, mpox), live |
| 105 | vaccinia (smallpox) diluted |
| 79 | vaccinia immune globulin |
| 21 | varicella |
| 81 | VEE, inactivated |
| 80 | VEE, live |
| 92 | VEE, unspecified formulation |
| 36 | VZIG |
| 117 | VZIG (IND) |
| 37 | yellow fever live |
| 121 | zoster live |
| 998 | no vaccine administered |
| 999 | unknown |
| 99 | RESERVED - do not use |
| 133 | Pneumococcal conjugate PCV 13 |
| 134 | Japanese Encephalitis IM |
| 137 | HPV, unspecified formulation |
| 136 | Meningococcal MCV4O |
| 135 | Influenza, high-dose, trivalent, PF |
| 131 | typhus, historical |
| 132 | DTaP-IPV-HIB-HEP B, historical |
| 128 | Novel Influenza-H1N1-09, all formulations |
| 125 | Novel Influenza-H1N1-09, nasal |
| 126 | Novel influenza-H1N1-09, preservative-free |
| 127 | Novel influenza-H1N1-09 |
| 138 | Td (adult) |
| 139 | Td(adult) unspecified formulation |
| 140 | Influenza, split virus, trivalent, PF |
| 129 | Japanese Encephalitis, unspecified formulation |
| 141 | Influenza, split virus, trivalent, preservative |
| 142 | tetanus toxoid, not adsorbed |
| 143 | Adenovirus types 4 and 7 |
| 144 | influenza, seasonal, intradermal, preservative free |
| 145 | RSV-MAb (new) |
| 146 | DTaP,IPV,Hib,HepB |
| 147 | meningococcal MCV4, unspecified formulation |
| 148 | Meningococcal C/Y-HIB PRP |
| 149 | Influenza, live, quadrivalent, intranasal |
| 150 | Influenza, split virus, quadrivalent, PF |
| 151 | influenza nasal, unspecified formulation |
| 152 | Pneumococcal Conjugate, unspecified formulation |
| 153 | Influenza, MDCK, trivalent, PF |
| 154 | Hep A, IG |
| 155 | Influenza, recombinant, trivalent, PF |
| 156 | Rho(D)-IG |
| 157 | Rho(D) -IG IM |
| 158 | Influenza, split virus, quadrivalent, preservative |
| 159 | Rho(D) - Unspecified formulation |
| 160 | Influenza A monovalent (H5N1), ADJUVANTED-2013 |
| 801 | AS03 Adjuvant |
| 161 | Influenza, injectable,quadrivalent, preservative free, pediatric |
| 162 | meningococcal B, recombinant |
| 163 | meningococcal B, OMV |
| 164 | meningococcal B, unspecified |
| 165 | HPV9 |
| 166 | influenza, intradermal, quadrivalent, preservative free |
| 167 | meningococcal, unknown serogroups |
| 168 | Influenza, adjuvanted, trivalent, PF |
| 169 | Hep A, live attenuated |
| 170 | DTAP/IPV/HIB - non-US |
| 171 | Influenza, MDCK, quadrivalent, PF |
| 172 | cholera, WC-rBS |
| 173 | cholera, BivWC |
| 174 | cholera, live attenuated |
| 175 | Rabies - IM Diploid cell culture |
| 176 | Rabies - IM fibroblast culture |
| 177 | PCV10 |
| 178 | OPV bivalent |
| 179 | OPV ,monovalent, unspecified |
| 180 | tetanus immune globulin |
| 181 | anthrax immune globulin |
| 182 | OPV, Unspecified |
| 183 | Yellow fever vaccine live - alt |
| 184 | Yellow fever, unspecified |
| 185 | Influenza, recombinant, quadrivalent, PF |
| 186 | Influenza, MDCK, quadrivalent, preservative |
| 187 | zoster recombinant |
| 188 | zoster, unspecified formulation |
| 189 | HepB-CpG |
| 190 | Typhoid conjugate vaccine (TCV) |
| 191 | meningococcal A polysaccharide (non-US) |
| 192 | meningococcal AC polysaccharide (non-US) |
| 193 | Hep A-Hep B, pediatric/adolescent |
| 194 | Influenza, Southern Hemisphere |
| 195 | DT, IPV adsorbed |
| 196 | Td, adsorbed, preservative free, adult use, Lf unspecified |
| 197 | Influenza, high-dose, quadrivalent, PF |
| 200 | influenza, Southern Hemisphere, pediatric, preservative free |
| 201 | Influenza, Southern Hemisphere, quadrivalent, PF |
| 202 | influenza, Southern Hemisphere, quadrivalent, with preservative |
| 198 | DTP-hepB-Hib Pentavalent Non-US |
| 203 | meningococcal conjugate quadrivalent, MenACWY-TT (MCV4) |
| 205 | Influenza, adjuvanted, quadrivalent, PF |
| 206 | Vaccinia, smallpox Mpox vaccine live, PF, SQ or ID injection |
| 207 | COVID-19, mRNA, LNP-S, PF, 100 mcg/0.5mL dose or 50 mcg/0.25mL dose |
| 208 | COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose |
| 213 | SARS-COV-2 (COVID-19) vaccine, UNSPECIFIED |
| 210 | COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL |
| 212 | COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL |
| 204 | Ebola Zaire vaccine, live, recombinant, 1mL dose |
| 214 | Ebola, unspecified |
| 211 | COVID-19, subunit, rS-nanoparticle+Matrix-M1 Adjuvant, PF, 0.5 mL |
| 500 | COVID-19 Non-US Vaccine, Product Unknown |
| 501 | COVID-19 IV Non-US Vaccine (QAZCOVID-IN) |
| 502 | COVID-19 IV Non-US Vaccine (COVAXIN) |
| 503 | COVID-19 LAV Non-US Vaccine (COVIVAC) |
| 504 | COVID-19 VVnr Non-US Vaccine (Sputnik Light) |
| 505 | COVID-19 VVnr Non-US Vaccine (Sputnik V) |
| 506 | COVID-19 VVnr Non-US Vaccine (CanSino Biological Inc./Beijing Institute of Biotechnology |
| 507 | COVID-19 PS Non-US Vaccine (Anhui Zhifei Longcom Biopharm + Inst of Micro, Chinese Acad of Sciences) |
| 508 | COVID-19 PS Non-US Vaccine (Jiangsu Province Centers for Disease Control and Prevention) |
| 509 | COVID-19 PS Non-US Vaccine (EpiVacCorona) |
| 510 | COVID-19 IV Non-US Vaccine (BIBP, Sinopharm) |
| 511 | COVID-19 IV Non-US Vaccine (CoronaVac, Sinovac) |
| 215 | Pneumococcal conjugate PCV15, polysaccharide CRM197 conjugate, adjuvant, PF |
| 216 | Pneumococcal conjugate PCV20, polysaccharide CRM197 conjugate, adjuvant, PF |
| 219 | COVID-19, mRNA, LNP-S, PF, 3 mcg/0.2 mL dose, tris-sucrose |
| 217 | COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose, tris-sucrose |
| 218 | COVID-19, mRNA, LNP-S, PF, 10 mcg/0.2 mL dose, tris-sucrose |
| 220 | HepB recombinant, 3-antigen, Al(OH)3 |
| 221 | COVID-19, mRNA, LNP-S, PF, 50 mcg/0.5 mL dose |
| 222 | Tick-borne encephalitis, unspecified |
| 223 | Tick-borne encephalitis, inactivated, PF, 0.25mL |
| 224 | Tick-borne encephalitis, inactivated, PF, 0.5mL |
| 225 | COVID-19, D614, recomb, preS dTM, AS03 adjuvant add, PF, 5mcg/0.5mL |
| 226 | COVID-19, D614, recomb, preS dTM, AS03 adjuvant add, PF, 10mcg/0.5mL |
| 512 | SARS-COV-2 COVID-19 VLP Non-US Vaccine (Medicago, Covifenz) |
| 513 | SARS-COV-2 COVID-19 PS Non-US Vaccine (Anhui Zhifei Longcom, Zifivax) |
| 514 | SARS-COV-2 COVID-19 DNA Non-US Vaccine (Zydus Cadila, ZyCoV-D) |
| 515 | SARS-COV-2 COVID-19 PS Non-US Vaccine (Medigen, MVC-COV1901) |
| 516 | COV-2 COVID-19 Inactivated Non-US Vaccine Product (Minhai Biotechnology Co, KCONVAC) |
| 517 | SARS-COV-2 COVID-19 PS Non-US Vaccine (Biological E Limited, Corbevax) |
| 227 | COVID-19, mRNA, LNP-S, PF, pediatric 50 mcg/0.5 mL dose |
| 228 | COVID-19, mRNA, LNP-S, PF, pediatric 25 mcg/0.25 mL dose |
| 229 | COVID-19, mRNA, LNP-S, bivalent, PF, 50 mcg/0.5 mL or 25mcg/0.25 mL dose |
| 301 | COVID-19, mRNA, LNP-S, bivalent, PF, 10 mcg/0.2 mL dose |
| 300 | COVID-19, mRNA, LNP-S, bivalent, PF, 30 mcg/0.3 mL dose |
| 230 | COVID-19, mRNA, LNP-S, bivalent, PF, 10 mcg/0.2 mL |
| 518 | COVID-19 Inactivated, Non-US Vaccine (VLA2001, Valneva) |
| 519 | COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine (Spikevax Bivalent), Moderna |
| 520 | COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine Product, Pfizer-BioNTech |
| 521 | COVID-19 SP, protein-based, adjuvanted (VidPrevtyn Beta), Sanofi-GSK |
| 231 | influenza, Southern Hemisphere, high-dose, quadrivalent |
| 303 | RSV, recombinant, protein subunit RSVpreF, adjuvant reconstituted, 0.5 mL, PF |
| 304 | Respiratory syncytial virus (RSV), unspecified |
| 305 | RSV, bivalent, protein subunit RSVpreF, diluent reconstituted, 0.5 mL, PF |
| 306 | RSV, mAb, nirsevimab-alip, 0.5 mL, neonate to 24 months |
| 307 | RSV, mAb, nirsevimab-alip, 1 mL, neonate to 24 months |
| 313 | COVID-19, subunit, rS-nanoparticle, adjuvanted, PF, 5 mcg/0.5 mL |
| 308 | COVID-19, mRNA, LNP-S, PF, tris-sucrose, 3 mcg/0.3 mL |
| 309 | COVID-19, mRNA, LNP-S, PF, tris-sucrose, 30 mcg/0.3 mL |
| 310 | COVID-19, mRNA, LNP-S, PF, tris-sucrose, 10 mcg/0.3 mL |
| 312 | COVID-19, mRNA, LNP-S, PF, 50 mcg/0.5 mL |
| 311 | COVID-19, mRNA, LNP-S, PF, 25 mcg/0.25 mL |
| 315 | Respiratory syncytial virus (RSV) MAB, unspecified |
| 314 | Respiratory syncytial virus (RSV) vaccine, unspecified |
| 316 | Meningococcal polysaccharide (MenACWY-TT conjugate), (MenB), PF |
| 317 | Chikungunya live attenuated vaccine, 0.5 mL, PF |
| 318 | Anthrax, post-exposure prophylaxis |
| 319 | Anthrax vaccine, unspecified |
| 320 | Influenza, MDCK, trivalent, preservative |
| 321 | Influenza-avian, H5N8, monovalent, PF |
| 322 | Influenza-avian, H5N8, monovalent, preservative |
| 324 | Poliovirus, inactivated, fractional-dose (fIPV) |
| 323 | Influenza-avian, H5, unspecified formulation |
| 326 | RSV, mRNA, injectable, PF |
| 327 | Pneumococcal conjugate PCV21, polysaccharide CRM197 conjugate, PF |
| 328 | Meningococcal oligosaccharide (MenACWY), (MenB), PF |
| 329 | Chikungunya, VLP, recombinant, 0.8 mL, PF |
| 330 | Dengue fever, unspecified |
| 331 | Influenza, Southern Hemisphere, trivalent, PF |
| 325 | Vaccinia (smallpox, mpox), unspecified |
| 332 | RSV, mAb, clesrovimab-cfor, 0.7 mL, neonate and infant, PF |
| 333 | Influenza, live, trivalent, intranasal, self/caregiver admin, PF |
| 302 | COVID-19, mRNA, LNP-S, bivalent, PF, 3 mcg/0.2 mL dose |
Source1
{
"resourceType": "ValueSet",
"id": "immunization-all-cvx",
"text": {
"status": "generated",
"div": "<!-- snip (see above) -->"
},
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-wg",
"valueCode": "pher"
},
{
"url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-fmm",
"valueInteger": 4,
"_valueInteger": {
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-conformance-derivedFrom",
"valueCanonical": "http://hl7.org/fhir/uv/shc-vaccination/ImplementationGuide/hl7.fhir.uv.shc-vaccination"
}
]
}
},
{
"url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-standards-status",
"valueCode": "trial-use",
"_valueCode": {
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-conformance-derivedFrom",
"valueCanonical": "http://hl7.org/fhir/uv/shc-vaccination/ImplementationGuide/hl7.fhir.uv.shc-vaccination"
}
]
}
}
],
"url": "http://hl7.org/fhir/uv/shc-vaccination/ValueSet/immunization-all-cvx",
"version": "1.0.0",
"name": "ImmunizationAllCvxValueSet",
"title": "Immunization / All / CVX",
"status": "active",
"experimental": false,
"date": "2025-09-03T20:15:06+00:00",
"publisher": "HL7 International / Public Health",
"contact": [
{
"name": "HL7 International / Public Health",
"telecom": [
{
"system": "url",
"value": "http://www.hl7.org/Special/committees/pher"
},
{
"system": "email",
"value": "vci-ig@mitre.org"
}
]
}
],
"description": "Contains all CVX codes from <https://www2.cdc.gov/vaccines/iis/iisstandards/vaccines.asp?rpt=cvx> as of 2025-09-03. This list of codes will not update automatically, so please refer to this URL for\nthe most up-to-date codes.the most up-to-date codes.",
"jurisdiction": [
{
"coding": [
{
"system": "http://unstats.un.org/unsd/methods/m49/m49.htm",
"code": "001"
}
]
}
],
"compose": {
"include": [
{
"system": "http://hl7.org/fhir/sid/cvx",
"concept": [
{
"code": "54",
"display": "adenovirus, type 4"
},
{
"code": "55",
"display": "adenovirus, type 7"
},
{
"code": "82",
"display": "adenovirus, unspecified formulation"
},
{
"code": "24",
"display": "Anthrax, pre-exposure prophylaxis, post-exposure prophylaxis"
},
{
"code": "19",
"display": "BCG"
},
{
"code": "27",
"display": "botulinum antitoxin"
},
{
"code": "26",
"display": "cholera, unspecified formulation"
},
{
"code": "29",
"display": "CMVIG"
},
{
"code": "56",
"display": "dengue fever tetravalent"
},
{
"code": "12",
"display": "diphtheria antitoxin"
},
{
"code": "28",
"display": "DT (pediatric)"
},
{
"code": "20",
"display": "DTaP"
},
{
"code": "106",
"display": "DTaP, 5 pertussis antigens"
},
{
"code": "107",
"display": "DTaP, unspecified formulation"
},
{
"code": "110",
"display": "DTaP-Hep B-IPV"
},
{
"code": "50",
"display": "DTaP-Hib"
},
{
"code": "120",
"display": "DTaP-Hib-IPV"
},
{
"code": "130",
"display": "DTaP-IPV"
},
{
"code": "22",
"display": "DTP-Hib"
},
{
"code": "102",
"display": "DTP-Hib-Hep B"
},
{
"code": "57",
"display": "hantavirus"
},
{
"code": "52",
"display": "Hep A, adult"
},
{
"code": "83",
"display": "Hep A, ped/adol, 2 dose"
},
{
"code": "84",
"display": "Hep A, ped/adol, 3 dose"
},
{
"code": "31",
"display": "Hep A, pediatric, unspecified formulation"
},
{
"code": "85",
"display": "Hep A, unspecified formulation"
},
{
"code": "104",
"display": "Hep A-Hep B"
},
{
"code": "30",
"display": "HBIG"
},
{
"code": "42",
"display": "Hep B, adolescent/high risk infant"
},
{
"code": "43",
"display": "Hep B, adult"
},
{
"code": "44",
"display": "Hep B, high-dosage, dialysis or IC"
},
{
"code": "45",
"display": "Hep B, unspecified formulation"
},
{
"code": "58",
"display": "Hep C"
},
{
"code": "59",
"display": "Hep E"
},
{
"code": "60",
"display": "herpes simplex 2"
},
{
"code": "46",
"display": "Hib (PRP-D)"
},
{
"code": "47",
"display": "Hib (HbOC)"
},
{
"code": "48",
"display": "Hib (PRP-T)"
},
{
"code": "49",
"display": "Hib (PRP-OMP)"
},
{
"code": "17",
"display": "Hib, unspecified formulation"
},
{
"code": "51",
"display": "Hib-Hep B"
},
{
"code": "61",
"display": "HIV"
},
{
"code": "118",
"display": "HPV, bivalent"
},
{
"code": "62",
"display": "HPV, quadrivalent"
},
{
"code": "86",
"display": "IG"
},
{
"code": "87",
"display": "IGIV"
},
{
"code": "14",
"display": "IG, unspecified formulation"
},
{
"code": "111",
"display": "Influenza, live, trivalent, intranasal, PF"
},
{
"code": "15",
"display": "influenza, split (incl. purified surface antigen)"
},
{
"code": "16",
"display": "influenza, whole"
},
{
"code": "88",
"display": "influenza, unspecified formulation"
},
{
"code": "123",
"display": "influenza, H5N1-1203"
},
{
"code": "10",
"display": "IPV"
},
{
"code": "89",
"display": "polio, unspecified formulation"
},
{
"code": "39",
"display": "Japanese encephalitis SC"
},
{
"code": "63",
"display": "Junin virus"
},
{
"code": "64",
"display": "leishmaniasis"
},
{
"code": "65",
"display": "leprosy"
},
{
"code": "66",
"display": "Lyme disease"
},
{
"code": "94",
"display": "MMRV"
},
{
"code": "67",
"display": "malaria"
},
{
"code": "68",
"display": "melanoma"
},
{
"code": "32",
"display": "meningococcal MPSV4"
},
{
"code": "103",
"display": "meningococcal C conjugate"
},
{
"code": "114",
"display": "meningococcal MCV4P"
},
{
"code": "108",
"display": "meningococcal ACWY, unspecified formulation"
},
{
"code": "69",
"display": "parainfluenza-3"
},
{
"code": "11",
"display": "pertussis"
},
{
"code": "23",
"display": "plague"
},
{
"code": "33",
"display": "pneumococcal polysaccharide PPV23"
},
{
"code": "100",
"display": "pneumococcal conjugate PCV 7"
},
{
"code": "109",
"display": "pneumococcal, unspecified formulation"
},
{
"code": "70",
"display": "Q fever"
},
{
"code": "18",
"display": "rabies, intramuscular injection"
},
{
"code": "40",
"display": "rabies, intradermal injection"
},
{
"code": "90",
"display": "rabies, unspecified formulation"
},
{
"code": "72",
"display": "rheumatic fever"
},
{
"code": "73",
"display": "Rift Valley fever"
},
{
"code": "34",
"display": "RIG"
},
{
"code": "119",
"display": "rotavirus, monovalent"
},
{
"code": "122",
"display": "rotavirus, unspecified formulation"
},
{
"code": "116",
"display": "rotavirus, pentavalent"
},
{
"code": "74",
"display": "rotavirus, tetravalent"
},
{
"code": "71",
"display": "RSV-IGIV"
},
{
"code": "93",
"display": "RSV-MAb"
},
{
"code": "38",
"display": "rubella/mumps"
},
{
"code": "76",
"display": "Staphylococcus bacterio lysate"
},
{
"code": "113",
"display": "Td (adult), 5 Lf tetanus toxoid, preservative free, adsorbed"
},
{
"code": "115",
"display": "Tdap"
},
{
"code": "35",
"display": "tetanus toxoid, adsorbed"
},
{
"code": "112",
"display": "tetanus toxoid, unspecified formulation"
},
{
"code": "77",
"display": "Tick-borne encephalitis vaccine (non-US)"
},
{
"code": "13",
"display": "TIG"
},
{
"code": "95",
"display": "TST-OT tine test"
},
{
"code": "96",
"display": "TST-PPD intradermal"
},
{
"code": "97",
"display": "TST-PPD tine test"
},
{
"code": "98",
"display": "TST, unspecified formulation"
},
{
"code": "78",
"display": "tularemia vaccine"
},
{
"code": "91",
"display": "typhoid, unspecified formulation"
},
{
"code": "25",
"display": "typhoid, oral"
},
{
"code": "41",
"display": "typhoid, parenteral"
},
{
"code": "53",
"display": "typhoid, parenteral, AKD (U.S. military)"
},
{
"code": "101",
"display": "typhoid, ViCPs"
},
{
"code": "75",
"display": "Vaccinia (smallpox, mpox), live"
},
{
"code": "105",
"display": "vaccinia (smallpox) diluted"
},
{
"code": "79",
"display": "vaccinia immune globulin"
},
{
"code": "21",
"display": "varicella"
},
{
"code": "81",
"display": "VEE, inactivated"
},
{
"code": "80",
"display": "VEE, live"
},
{
"code": "92",
"display": "VEE, unspecified formulation"
},
{
"code": "36",
"display": "VZIG"
},
{
"code": "117",
"display": "VZIG (IND)"
},
{
"code": "37",
"display": "yellow fever live"
},
{
"code": "121",
"display": "zoster live"
},
{
"code": "998",
"display": "no vaccine administered"
},
{
"code": "999",
"display": "unknown"
},
{
"code": "99",
"display": "RESERVED - do not use"
},
{
"code": "133",
"display": "Pneumococcal conjugate PCV 13"
},
{
"code": "134",
"display": "Japanese Encephalitis IM"
},
{
"code": "137",
"display": "HPV, unspecified formulation"
},
{
"code": "136",
"display": "Meningococcal MCV4O"
},
{
"code": "135",
"display": "Influenza, high-dose, trivalent, PF"
},
{
"code": "131",
"display": "typhus, historical"
},
{
"code": "132",
"display": "DTaP-IPV-HIB-HEP B, historical"
},
{
"code": "128",
"display": "Novel Influenza-H1N1-09, all formulations"
},
{
"code": "125",
"display": "Novel Influenza-H1N1-09, nasal"
},
{
"code": "126",
"display": "Novel influenza-H1N1-09, preservative-free"
},
{
"code": "127",
"display": "Novel influenza-H1N1-09"
},
{
"code": "138",
"display": "Td (adult)"
},
{
"code": "139",
"display": "Td(adult) unspecified formulation"
},
{
"code": "140",
"display": "Influenza, split virus, trivalent, PF"
},
{
"code": "129",
"display": "Japanese Encephalitis, unspecified formulation"
},
{
"code": "141",
"display": "Influenza, split virus, trivalent, preservative"
},
{
"code": "142",
"display": "tetanus toxoid, not adsorbed"
},
{
"code": "143",
"display": "Adenovirus types 4 and 7"
},
{
"code": "144",
"display": "influenza, seasonal, intradermal, preservative free"
},
{
"code": "145",
"display": "RSV-MAb (new)"
},
{
"code": "146",
"display": "DTaP,IPV,Hib,HepB"
},
{
"code": "147",
"display": "meningococcal MCV4, unspecified formulation"
},
{
"code": "148",
"display": "Meningococcal C/Y-HIB PRP"
},
{
"code": "149",
"display": "Influenza, live, quadrivalent, intranasal"
},
{
"code": "150",
"display": "Influenza, split virus, quadrivalent, PF"
},
{
"code": "151",
"display": "influenza nasal, unspecified formulation"
},
{
"code": "152",
"display": "Pneumococcal Conjugate, unspecified formulation"
},
{
"code": "153",
"display": "Influenza, MDCK, trivalent, PF"
},
{
"code": "154",
"display": "Hep A, IG"
},
{
"code": "155",
"display": "Influenza, recombinant, trivalent, PF"
},
{
"code": "156",
"display": "Rho(D)-IG"
},
{
"code": "157",
"display": "Rho(D) -IG IM"
},
{
"code": "158",
"display": "Influenza, split virus, quadrivalent, preservative"
},
{
"code": "159",
"display": "Rho(D) - Unspecified formulation"
},
{
"code": "160",
"display": "Influenza A monovalent (H5N1), ADJUVANTED-2013"
},
{
"code": "801",
"display": "AS03 Adjuvant"
},
{
"code": "161",
"display": "Influenza, injectable,quadrivalent, preservative free, pediatric"
},
{
"code": "162",
"display": "meningococcal B, recombinant"
},
{
"code": "163",
"display": "meningococcal B, OMV"
},
{
"code": "164",
"display": "meningococcal B, unspecified"
},
{
"code": "165",
"display": "HPV9"
},
{
"code": "166",
"display": "influenza, intradermal, quadrivalent, preservative free"
},
{
"code": "167",
"display": "meningococcal, unknown serogroups"
},
{
"code": "168",
"display": "Influenza, adjuvanted, trivalent, PF"
},
{
"code": "169",
"display": "Hep A, live attenuated"
},
{
"code": "170",
"display": "DTAP/IPV/HIB - non-US"
},
{
"code": "171",
"display": "Influenza, MDCK, quadrivalent, PF"
},
{
"code": "172",
"display": "cholera, WC-rBS"
},
{
"code": "173",
"display": "cholera, BivWC"
},
{
"code": "174",
"display": "cholera, live attenuated"
},
{
"code": "175",
"display": "Rabies - IM Diploid cell culture"
},
{
"code": "176",
"display": "Rabies - IM fibroblast culture"
},
{
"code": "177",
"display": "PCV10"
},
{
"code": "178",
"display": "OPV bivalent"
},
{
"code": "179",
"display": "OPV ,monovalent, unspecified"
},
{
"code": "180",
"display": "tetanus immune globulin"
},
{
"code": "181",
"display": "anthrax immune globulin"
},
{
"code": "182",
"display": "OPV, Unspecified"
},
{
"code": "183",
"display": "Yellow fever vaccine live - alt"
},
{
"code": "184",
"display": "Yellow fever, unspecified"
},
{
"code": "185",
"display": "Influenza, recombinant, quadrivalent, PF"
},
{
"code": "186",
"display": "Influenza, MDCK, quadrivalent, preservative"
},
{
"code": "187",
"display": "zoster recombinant"
},
{
"code": "188",
"display": "zoster, unspecified formulation"
},
{
"code": "189",
"display": "HepB-CpG"
},
{
"code": "190",
"display": "Typhoid conjugate vaccine (TCV)"
},
{
"code": "191",
"display": "meningococcal A polysaccharide (non-US)"
},
{
"code": "192",
"display": "meningococcal AC polysaccharide (non-US)"
},
{
"code": "193",
"display": "Hep A-Hep B, pediatric/adolescent"
},
{
"code": "194",
"display": "Influenza, Southern Hemisphere"
},
{
"code": "195",
"display": "DT, IPV adsorbed"
},
{
"code": "196",
"display": "Td, adsorbed, preservative free, adult use, Lf unspecified"
},
{
"code": "197",
"display": "Influenza, high-dose, quadrivalent, PF"
},
{
"code": "200",
"display": "influenza, Southern Hemisphere, pediatric, preservative free"
},
{
"code": "201",
"display": "Influenza, Southern Hemisphere, quadrivalent, PF"
},
{
"code": "202",
"display": "influenza, Southern Hemisphere, quadrivalent, with preservative"
},
{
"code": "198",
"display": "DTP-hepB-Hib Pentavalent Non-US"
},
{
"code": "203",
"display": "meningococcal conjugate quadrivalent, MenACWY-TT (MCV4)"
},
{
"code": "205",
"display": "Influenza, adjuvanted, quadrivalent, PF"
},
{
"code": "206",
"display": "Vaccinia, smallpox Mpox vaccine live, PF, SQ or ID injection"
},
{
"code": "207",
"display": "COVID-19, mRNA, LNP-S, PF, 100 mcg/0.5mL dose or 50 mcg/0.25mL dose"
},
{
"code": "208",
"display": "COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose"
},
{
"code": "213",
"display": "SARS-COV-2 (COVID-19) vaccine, UNSPECIFIED"
},
{
"code": "210",
"display": "COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL"
},
{
"code": "212",
"display": "COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL"
},
{
"code": "204",
"display": "Ebola Zaire vaccine, live, recombinant, 1mL dose"
},
{
"code": "214",
"display": "Ebola, unspecified"
},
{
"code": "211",
"display": "COVID-19, subunit, rS-nanoparticle+Matrix-M1 Adjuvant, PF, 0.5 mL"
},
{
"code": "500",
"display": "COVID-19 Non-US Vaccine, Product Unknown"
},
{
"code": "501",
"display": "COVID-19 IV Non-US Vaccine (QAZCOVID-IN)"
},
{
"code": "502",
"display": "COVID-19 IV Non-US Vaccine (COVAXIN)"
},
{
"code": "503",
"display": "COVID-19 LAV Non-US Vaccine (COVIVAC)"
},
{
"code": "504",
"display": "COVID-19 VVnr Non-US Vaccine (Sputnik Light)"
},
{
"code": "505",
"display": "COVID-19 VVnr Non-US Vaccine (Sputnik V)"
},
{
"code": "506",
"display": "COVID-19 VVnr Non-US Vaccine (CanSino Biological Inc./Beijing Institute of Biotechnology"
},
{
"code": "507",
"display": "COVID-19 PS Non-US Vaccine (Anhui Zhifei Longcom Biopharm + Inst of Micro, Chinese Acad of Sciences)"
},
{
"code": "508",
"display": "COVID-19 PS Non-US Vaccine (Jiangsu Province Centers for Disease Control and Prevention)"
},
{
"code": "509",
"display": "COVID-19 PS Non-US Vaccine (EpiVacCorona)"
},
{
"code": "510",
"display": "COVID-19 IV Non-US Vaccine (BIBP, Sinopharm)"
},
{
"code": "511",
"display": "COVID-19 IV Non-US Vaccine (CoronaVac, Sinovac)"
},
{
"code": "215",
"display": "Pneumococcal conjugate PCV15, polysaccharide CRM197 conjugate, adjuvant, PF"
},
{
"code": "216",
"display": "Pneumococcal conjugate PCV20, polysaccharide CRM197 conjugate, adjuvant, PF"
},
{
"code": "219",
"display": "COVID-19, mRNA, LNP-S, PF, 3 mcg/0.2 mL dose, tris-sucrose"
},
{
"code": "217",
"display": "COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose, tris-sucrose"
},
{
"code": "218",
"display": "COVID-19, mRNA, LNP-S, PF, 10 mcg/0.2 mL dose, tris-sucrose"
},
{
"code": "220",
"display": "HepB recombinant, 3-antigen, Al(OH)3"
},
{
"code": "221",
"display": "COVID-19, mRNA, LNP-S, PF, 50 mcg/0.5 mL dose"
},
{
"code": "222",
"display": "Tick-borne encephalitis, unspecified"
},
{
"code": "223",
"display": "Tick-borne encephalitis, inactivated, PF, 0.25mL"
},
{
"code": "224",
"display": "Tick-borne encephalitis, inactivated, PF, 0.5mL"
},
{
"code": "225",
"display": "COVID-19, D614, recomb, preS dTM, AS03 adjuvant add, PF, 5mcg/0.5mL"
},
{
"code": "226",
"display": "COVID-19, D614, recomb, preS dTM, AS03 adjuvant add, PF, 10mcg/0.5mL"
},
{
"code": "512",
"display": "SARS-COV-2 COVID-19 VLP Non-US Vaccine (Medicago, Covifenz)"
},
{
"code": "513",
"display": "SARS-COV-2 COVID-19 PS Non-US Vaccine (Anhui Zhifei Longcom, Zifivax)"
},
{
"code": "514",
"display": "SARS-COV-2 COVID-19 DNA Non-US Vaccine (Zydus Cadila, ZyCoV-D)"
},
{
"code": "515",
"display": "SARS-COV-2 COVID-19 PS Non-US Vaccine (Medigen, MVC-COV1901)"
},
{
"code": "516",
"display": "COV-2 COVID-19 Inactivated Non-US Vaccine Product (Minhai Biotechnology Co, KCONVAC)"
},
{
"code": "517",
"display": "SARS-COV-2 COVID-19 PS Non-US Vaccine (Biological E Limited, Corbevax)"
},
{
"code": "227",
"display": "COVID-19, mRNA, LNP-S, PF, pediatric 50 mcg/0.5 mL dose"
},
{
"code": "228",
"display": "COVID-19, mRNA, LNP-S, PF, pediatric 25 mcg/0.25 mL dose"
},
{
"code": "229",
"display": "COVID-19, mRNA, LNP-S, bivalent, PF, 50 mcg/0.5 mL or 25mcg/0.25 mL dose"
},
{
"code": "301",
"display": "COVID-19, mRNA, LNP-S, bivalent, PF, 10 mcg/0.2 mL dose"
},
{
"code": "300",
"display": "COVID-19, mRNA, LNP-S, bivalent, PF, 30 mcg/0.3 mL dose"
},
{
"code": "230",
"display": "COVID-19, mRNA, LNP-S, bivalent, PF, 10 mcg/0.2 mL"
},
{
"code": "518",
"display": "COVID-19 Inactivated, Non-US Vaccine (VLA2001, Valneva)"
},
{
"code": "519",
"display": "COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine (Spikevax Bivalent), Moderna"
},
{
"code": "520",
"display": "COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine Product, Pfizer-BioNTech"
},
{
"code": "521",
"display": "COVID-19 SP, protein-based, adjuvanted (VidPrevtyn Beta), Sanofi-GSK"
},
{
"code": "231",
"display": "influenza, Southern Hemisphere, high-dose, quadrivalent"
},
{
"code": "303",
"display": "RSV, recombinant, protein subunit RSVpreF, adjuvant reconstituted, 0.5 mL, PF"
},
{
"code": "304",
"display": "Respiratory syncytial virus (RSV), unspecified"
},
{
"code": "305",
"display": "RSV, bivalent, protein subunit RSVpreF, diluent reconstituted, 0.5 mL, PF"
},
{
"code": "306",
"display": "RSV, mAb, nirsevimab-alip, 0.5 mL, neonate to 24 months"
},
{
"code": "307",
"display": "RSV, mAb, nirsevimab-alip, 1 mL, neonate to 24 months"
},
{
"code": "313",
"display": "COVID-19, subunit, rS-nanoparticle, adjuvanted, PF, 5 mcg/0.5 mL"
},
{
"code": "308",
"display": "COVID-19, mRNA, LNP-S, PF, tris-sucrose, 3 mcg/0.3 mL"
},
{
"code": "309",
"display": "COVID-19, mRNA, LNP-S, PF, tris-sucrose, 30 mcg/0.3 mL"
},
{
"code": "310",
"display": "COVID-19, mRNA, LNP-S, PF, tris-sucrose, 10 mcg/0.3 mL"
},
{
"code": "312",
"display": "COVID-19, mRNA, LNP-S, PF, 50 mcg/0.5 mL"
},
{
"code": "311",
"display": "COVID-19, mRNA, LNP-S, PF, 25 mcg/0.25 mL"
},
{
"code": "315",
"display": "Respiratory syncytial virus (RSV) MAB, unspecified"
},
{
"code": "314",
"display": "Respiratory syncytial virus (RSV) vaccine, unspecified"
},
{
"code": "316",
"display": "Meningococcal polysaccharide (MenACWY-TT conjugate), (MenB), PF"
},
{
"code": "317",
"display": "Chikungunya live attenuated vaccine, 0.5 mL, PF"
},
{
"code": "318",
"display": "Anthrax, post-exposure prophylaxis"
},
{
"code": "319",
"display": "Anthrax vaccine, unspecified"
},
{
"code": "320",
"display": "Influenza, MDCK, trivalent, preservative"
},
{
"code": "321",
"display": "Influenza-avian, H5N8, monovalent, PF"
},
{
"code": "322",
"display": "Influenza-avian, H5N8, monovalent, preservative"
},
{
"code": "324",
"display": "Poliovirus, inactivated, fractional-dose (fIPV)"
},
{
"code": "323",
"display": "Influenza-avian, H5, unspecified formulation"
},
{
"code": "326",
"display": "RSV, mRNA, injectable, PF"
},
{
"code": "327",
"display": "Pneumococcal conjugate PCV21, polysaccharide CRM197 conjugate, PF"
},
{
"code": "328",
"display": "Meningococcal oligosaccharide (MenACWY), (MenB), PF"
},
{
"code": "329",
"display": "Chikungunya, VLP, recombinant, 0.8 mL, PF"
},
{
"code": "330",
"display": "Dengue fever, unspecified"
},
{
"code": "331",
"display": "Influenza, Southern Hemisphere, trivalent, PF"
},
{
"code": "325",
"display": "Vaccinia (smallpox, mpox), unspecified"
},
{
"code": "332",
"display": "RSV, mAb, clesrovimab-cfor, 0.7 mL, neonate and infant, PF"
},
{
"code": "333",
"display": "Influenza, live, trivalent, intranasal, self/caregiver admin, PF"
},
{
"code": "302",
"display": "COVID-19, mRNA, LNP-S, bivalent, PF, 3 mcg/0.2 mL dose"
}
]
}
]
}
}